Chang-Gyu Hahn - Publications

Affiliations: 
Pharmacology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Psychobiology Psychology, Nanoscience

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Featherstone RE, Li H, Sengar A, Borgmann-Winter KE, Melnychenko O, Crown LM, Gifford RL, Amirfathi F, Banerjee A, Parekh K, Heller M, Zhang W, Marc AD, Salter MW, Siegel SJ, ... Hahn CG, et al. Blocking Src-PSD-95 interaction rescues glutamatergic signaling dysregulation in schizophrenia. Biorxiv : the Preprint Server For Biology. PMID 38496466 DOI: 10.1101/2024.03.08.584132  0.35
2023 Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE. Editorial Expression of Concern: Altered neuregulin 1-erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia. Nature Medicine. PMID 38114668 DOI: 10.1038/s41591-023-02757-y  0.334
2021 Wu X, Shukla R, Alganem K, Zhang X, Eby HM, Devine EA, Depasquale E, Reigle J, Simmons M, Hahn MK, Au-Yeung C, Asgariroozbehani R, Hahn CG, Haroutunian V, Meller J, et al. Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity. Molecular Psychiatry. PMID 34272489 DOI: 10.1038/s41380-021-01205-y  0.384
2020 Wu X, Shukla R, Alganem K, Depasquale E, Reigle J, Simmons M, Hahn C, Haroutunian V, Meller J, Meador-Woodruff J, McCullumsmith R. Transcriptional Profile of Pyramidal Neurons in Chronic Schizophrenia Reveals Lamina-Specific Dysfunction of Neuronal Immunity Biological Psychiatry. 87: S347-S348. DOI: 10.1016/J.Biopsych.2020.02.892  0.377
2019 Hoffman GE, Bendl J, Voloudakis G, Montgomery KS, Sloofman L, Wang YC, Shah HR, Hauberg ME, Johnson JS, Girdhar K, Song L, Fullard JF, Kramer R, Hahn CG, Gur R, et al. CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. Scientific Data. 6: 180. PMID 31551426 DOI: 10.1038/S41597-019-0183-6  0.412
2019 Borgmann-Winter KE, Wang K, Bandyopadhyay S, Torshizi AD, Blair IA, Hahn CG. The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia. Schizophrenia Research. PMID 31416743 DOI: 10.1016/J.Schres.2019.07.025  0.398
2019 Ward KR, Featherstone RE, Naschek MJ, Melnychenko O, Banerjee A, Yi J, Gifford RL, Borgmann-Winter KE, Salter MW, Hahn CG, Siegel SJ. Src deficient mice demonstrate behavioral and electrophysiological alterations relevant to psychiatric and developmental disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30826459 DOI: 10.1016/J.Pnpbp.2019.02.017  0.355
2018 Rajarajan P, Borrman T, Liao W, Schrode N, Flaherty E, Casiño C, Powell S, Yashaswini C, LaMarca EA, Kassim B, Javidfar B, Espeso-Gil S, Li A, Won H, Geschwind DH, ... ... Hahn CG, et al. Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk. Science (New York, N.Y.). 362. PMID 30545851 DOI: 10.1126/Science.Aat4311  0.389
2018 Wang HY, MacDonald ML, Borgmann-Winter KE, Banerjee A, Sleiman P, Tom A, Khan A, Lee KC, Roussos P, Siegel SJ, Hemby SE, Bilker WB, Gur RE, Hahn CG. mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia. Molecular Psychiatry. PMID 30214040 DOI: 10.1038/S41380-018-0234-Y  0.445
2018 Hahn C. 14. Glutamatergic Signaling and PSD Proteome in Schizophrenia Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.031  0.435
2017 Chang X, Liu Y, Hahn CG, Gur RE, Sleiman PMA, Hakonarson H. RNA-seq analysis of amygdala tissue reveals characteristic expression profiles in schizophrenia. Translational Psychiatry. 7: e1203. PMID 28809853 DOI: 10.1038/Tp.2017.154  0.332
2017 Doyle GA, Crist RC, Karatas ET, Hammond MJ, Ewing AD, Ferraro TN, Hahn CG, Berrettini WH. Analysis of LINE-1 Elements in DNA from Postmortem Brains of Individuals with Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28585566 DOI: 10.1038/Npp.2017.115  0.325
2016 Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, Ruderfer DM, Oh EC, Topol A, Shah HR, Klei LL, Kramer R, Pinto D, Gümüş ZH, Cicek AE, ... ... Hahn CG, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nature Neuroscience. PMID 27668389 DOI: 10.1038/Nn.4399  0.337
2016 Schoch H, Kreibich AS, Ferri SL, White RS, Bohorquez D, Banerjee A, Port RG, Dow HC, Cordero L, Pallathra AA, Kim H, Li H, Bilker WB, Hirano S, Schultz RT, ... ... Hahn CG, et al. Sociability Deficits and Altered Amygdala Circuits in Mice Lacking Pcdh10, an Autism Associated Gene. Biological Psychiatry. PMID 27567313 DOI: 10.1016/J.Biopsych.2016.06.008  0.327
2016 Egbujo CN, Sinclair D, Hahn CG. Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia. Current Psychiatry Reports. 18: 77. PMID 27371030 DOI: 10.1007/S11920-016-0710-5  0.458
2016 Sinclair D, Cesare J, McMullen M, Carlson GC, Hahn CG, Borgmann-Winter KE. Effects of sex and DTNBP1 (dysbindin) null gene mutation on the developmental GluN2B-GluN2A switch in the mouse cortex and hippocampus. Journal of Neurodevelopmental Disorders. 8: 14. PMID 27134685 DOI: 10.1186/S11689-016-9148-7  0.419
2015 Borgmann-Winter KE, Wang HY, Ray R, Willis BR, Moberg PJ, Rawson NE, Gur RE, Turetsky BI, Hahn CG. Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia. Schizophrenia Bulletin. PMID 26373539 DOI: 10.1093/Schbul/Sbv129  0.436
2015 Egbujo CN, Sinclair D, Borgmann-Winter KE, Arnold SE, Turetsky BI, Hahn CG. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia. Schizophrenia Research. 168: 554-62. PMID 26260078 DOI: 10.1016/J.Schres.2015.07.026  0.439
2015 Tatard-Leitman VM, Jutzeler CR, Suh J, Saunders JA, Billingslea EN, Morita S, White R, Featherstone RE, Ray R, Ortinski PI, Banerjee A, Gandal MJ, Lin R, Alexandrescu A, Liang Y, ... ... Hahn CG, et al. Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biological Psychiatry. 77: 556-68. PMID 25156700 DOI: 10.1016/J.Biopsych.2014.06.026  0.373
2014 Banerjee A, Wang HY, Borgmann-Winter KE, MacDonald ML, Kaprielian H, Stucky A, Kvasic J, Egbujo C, Ray R, Talbot K, Hemby SE, Siegel SJ, Arnold SE, Sleiman P, Chang X, ... ... Hahn CG, et al. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia. Molecular Psychiatry. PMID 25330739 DOI: 10.1038/mp.2014.115  0.357
2014 Billingslea EN, Tatard-Leitman VM, Anguiano J, Jutzeler CR, Suh J, Saunders JA, Morita S, Featherstone RE, Ortinski PI, Gandal MJ, Lin R, Liang Y, Gur RE, Carlson GC, Hahn CG, et al. Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1603-13. PMID 24525709 DOI: 10.1038/Npp.2014.7  0.41
2014 Moberg PJ, Kamath V, Marchetto DM, Calkins ME, Doty RL, Hahn CG, Borgmann-Winter KE, Kohler CG, Gur RE, Turetsky BI. Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophrenia Bulletin. 40: 50-9. PMID 23641047 DOI: 10.1093/Schbul/Sbt049  0.324
2014 Brown A, Borgmann-Winter K, Hahn C, Role L, Talmage D, Gur RE, Chow J, Prado P, McCloskey T, Bulinski JC, Dwork A. Poster #T34 INCREASED STABILITY OF MICROTUBULES IN CULTURED OLFACTORY NEUROEPITHELIAL CELLS FROM INDIVIDUALS WITH SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70851-5  0.384
2013 Brown AS, Borgmann-Winter K, Hahn CG, Role L, Talmage D, Gur R, Chow J, Prado P, McCloskey T, Bao Y, Bulinski JC, Dwork AJ. Increased Stability of Microtubules in Cultured Olfactory Neuroepithelial Cells from Individuals with Schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 24513021 DOI: 10.1016/J.Pnpbp.2013.10.015  0.462
2013 Pantazopoulos H, Boyer-Boiteau A, Holbrook EH, Jang W, Hahn CG, Arnold SE, Berretta S. Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia. Schizophrenia Research. 150: 366-72. PMID 24035561 DOI: 10.1016/J.Schres.2013.08.013  0.411
2012 MacDonald ML, Ciccimaro E, Prakash A, Banerjee A, Seeholzer SH, Blair IA, Hahn CG. Biochemical fractionation and stable isotope dilution liquid chromatography-mass spectrometry for targeted and microdomain-specific protein quantification in human postmortem brain tissue Molecular and Cellular Proteomics. 11: 1670-1681. PMID 22942359 DOI: 10.1074/Mcp.M112.021766  0.326
2012 Hahn C, Banerjee A, MacDonald ML, Borgmann-Winter KE. Altered Intracellular Trafficking Of Nr1 Subunit In Schizophrenia Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70054-3  0.433
2011 Hahn CG. A Src link in schizophrenia Nature Medicine. 17: 425-427. PMID 21475235 DOI: 10.1038/Nm0411-425  0.475
2010 Hahn CG. A road less travelled: Unpacking the complex traits of schizophrenia Brain Research Bulletin. 83: 85. PMID 20546839 DOI: 10.1016/J.Brainresbull.2010.05.007  0.396
2010 Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Research Bulletin. 83: 132-9. PMID 20433909 DOI: 10.1016/J.Brainresbull.2010.04.011  0.446
2010 Yee KK, Pribitkin EA, Cowart BJ, Vainius AA, Klock CT, Rosen D, Feng P, McLean J, Hahn CG, Rawson NE. Neuropathology of the olfactory mucosa in chronic rhinosinusitis. American Journal of Rhinology & Allergy. 24: 110-20. PMID 20021743 DOI: 10.2500/Ajra.2010.24.3435  0.302
2009 Turetsky BI, Hahn CG, Borgmann-Winter K, Moberg PJ. Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophrenia Bulletin. 35: 1117-31. PMID 19793796 DOI: 10.1093/Schbul/Sbp111  0.456
2009 Ehrlichman RS, Luminais SN, White SL, Rudnick ND, Ma N, Dow HC, Kreibich AS, Abel T, Brodkin ES, Hahn CG, Siegel SJ. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Research. 1294: 116-27. PMID 19643092 DOI: 10.1016/J.Brainres.2009.07.065  0.38
2009 Tang J, LeGros RP, Louneva N, Yeh L, Cohen JW, Hahn CG, Blake DJ, Arnold SE, Talbot K. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Human Molecular Genetics. 18: 3851-63. PMID 19617633 DOI: 10.1093/Hmg/Ddp329  0.464
2009 Bodarky CL, Halene TB, Ehrlichman RS, Banerjee A, Ray R, Hahn CG, Jonak G, Siegel SJ. Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice. The Journal of Pharmacology and Experimental Therapeutics. 331: 308-18. PMID 19602553 DOI: 10.1124/Jpet.109.150938  0.319
2009 Turetsky BI, Hahn CG, Arnold SE, Moberg PJ. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 767-74. PMID 18754006 DOI: 10.1038/Npp.2008.139  0.439
2009 Tang J, LeGros RP, Louneva N, Yeh L, Cohen JW, Hahn C, Blake DJ, Arnold SE, Talbot K. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to altered dysbindin-1 gene expression Nature Precedings. DOI: 10.1038/Npre.2009.2779.1  0.404
2006 Talbot K, Cho DS, Ong WY, Benson MA, Han LY, Kazi HA, Kamins J, Hahn CG, Blake DJ, Arnold SE. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Human Molecular Genetics. 15: 3041-54. PMID 16980328 DOI: 10.1093/Hmg/Ddl246  0.358
2006 Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nature Medicine. 12: 824-8. PMID 16767099 DOI: 10.1038/Nm1418  0.458
2005 Hahn CG, Umapathy, Wang HY, Koneru R, Levinson DF, Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. Journal of Psychiatric Research. 39: 355-63. PMID 16044535 DOI: 10.1016/J.Jpsychires.2004.10.007  0.32
2005 Hahn CG, Gomez G, Restrepo D, Friedman E, Josiassen R, Pribitkin EA, Lowry LD, Gallop RJ, Rawson NE. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. The American Journal of Psychiatry. 162: 616-8. PMID 15741484 DOI: 10.1176/Appi.Ajp.162.3.616  0.354
2005 Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Progress in Brain Research. 147: 319-45. PMID 15581715 DOI: 10.1016/S0079-6123(04)47023-X  0.464
2004 Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. The Journal of Clinical Investigation. 113: 1353-63. PMID 15124027 DOI: 10.1172/Jci20425  0.464
2001 Arnold SE, Han LY, Moberg PJ, Turetsky BI, Gur RE, Trojanowski JQ, Hahn CG. Dysregulation of olfactory receptor neuron lineage in schizophrenia. Archives of General Psychiatry. 58: 829-35. PMID 11545665 DOI: 10.1001/Archpsyc.58.9.829  0.431
1999 Hahn C, Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder Bipolar Disorders. 1: 81-86. PMID 11252663 DOI: 10.1034/J.1399-5618.1999.010204.X  0.374
Show low-probability matches.